Sinovac Life Sciences Co., Ltd.
Sinovac Life Sciences Co., Ltd.
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Lot-to-Lot Consistency Clinical Trial of PCV13 | Pneumococcal Infectious Diseases | Not yet recruiting | Phase 3 | 2026-09-22 | NCT07832500 | |
| A Phase Ⅲ Clinical Study of SNA02-48 Injection | Bacterial Infections and Mycoses, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections, tetanus | Not yet recruiting | Phase 3 | 2026-06-08 | NCT07633119 | |
| Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days) | Pneumococcal Infectious Diseases | Not yet recruiting | Phase 3 | 2026-05-18 | NCT07593924 | |
| Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Not yet recruiting | Phase 1 | 2026-01-28 | NCT07374510 | |
| Clinical Trial of PCV24 in Infants Aged 2-23 Months | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, pneumococcal infection, streptococcal infection | Recruiting | Phase 1 | 2026-01-28 | NCT06800261 | |
| Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, pneumococcal infection, streptococcal infection | Recruiting | Phase 3 | 2026-01-28 | NCT06617715 | |
| Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, pneumococcal infection, streptococcal infection | Recruiting | Phase 2 | 2025-12-24 | NCT07300644 | |
| PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) | Rotavirus Gastroenteritis | Recruiting | Phase 2 | 2025-08-22 | NCT06967272 |